“…P24 assays developed by Perkin Elmer Life Sciences (Boston, MA) [26]- [29], NEN Life Science Products (Geneva, Switzerland) [30], and Biocentric (Bandol, France) [31] have been evaluated for use in resource-limited settings but sensitivity [27], reliability [27], [30], and false positives [31] have been cited as reasons limiting implementation of these tests in resource-limited settings. Alternative assays have been developed, however, for the detection of p24 as the basis for HIV quantification [32]- [36].…”